$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expand.....
Published: Jan-2013
|
$3,500.00
GBI Research has released its latest research, “Neurometabolic Disorders Market to 2017 - Novel therapies for Rare Diseases Such As Gaucher and Niemann-Pick Poised to Supersede Existing Therapies” whi.....
Published: Mar-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research – Diabetes Therapeutics Market to 2017- Better Glycemic Control and Reduced Potential Risk of Hypoglycemia to.....
Published: Feb-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Metabolic Disorders Therapeutics Market to 2017 – Patent Expiry of Lipitor in 2011 will Negatively Impact Dy.....
Published: Oct-2011
|
$3,500.00
GBI Research’s new report, “Diabetes Market to 2016 - Biguanides and Insulin Analogs to be the Largest Selling Anti-Diabetic Drugs”, provides in-depth analysis of unmet needs, drivers and barriers tha.....
Published: Oct-2010
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “The Future of Metabolic Disorder Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product .....
Published: Dec-2009
|